Live
Endpoints News#ASCO26: Personalized cancer vaccines may help brain cancer patients live longerEndpoints News#ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts sayFierceBiotechIn next-gen IO race in NSCLC, BioNTech/BMS and Pfizer are divided on overall survival approachIlluminaIllumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance SingaporeCellDecoding the spatiotemporal development of human meningesCellFronto-insular circuit mechanisms of accelerated intermittent theta burst stimulationCellPhysiological brain clearance architecture revealed by neuronal protein tracingFierceBiotechASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’Endpoints NewsCan AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and moreAgilentMettler-Toledo International vs Agilent Technologies: Which Is the Stronger Buy Today? - TrefisIlluminaIllumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360BioPharma DiveAt ASCO, Merck makes case for a ‘cornerstone’ cancer drug
10x Genomics Blog Apr 15, 2026

After the bell: 10x Genomics posts quarterly results May 7 - Stock Titan

After the bell: 10x Genomics posts quarterly results May 7 - Stock Titan

Original
Body unavailable. Use the original source.